Arabi, Yaseen M. http://orcid.org/0000-0001-5735-6241
Azoulay, Elie
Al-Dorzi, Hasan M.
Phua, Jason
Salluh, Jorge
Binnie, Alexandra
Hodgson, Carol
Angus, Derek C.
Cecconi, Maurizio
Du, Bin
Fowler, Rob
Gomersall, Charles D.
Horby, Peter
Juffermans, Nicole P.
Kesecioglu, Jozef
Kleinpell, Ruth M.
Machado, Flavia R.
Martin, Greg S.
Meyfroidt, Geert
Rhodes, Andrew
Rowan, Kathryn
Timsit, Jean-François
Vincent, Jean-Louis
Citerio, Giuseppe
Article History
Received: 20 December 2020
Accepted: 11 January 2021
First Online: 22 February 2021
Compliance with ethical standards
:
: YA is a member of a national committee for COVID-19 response, a Lead-Co Chair of the Think20 (T20) Taskforce for COVID-19, Saudi Arabia, an investigator on A Randomised, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) and a Board Member of the International Severe Acute Respiratory and Emerging Infection Consortium. J-F T is a member of Advisory Boards not directly related to the submitted manuscript but related to COVID-19: MSD, Gilead. His academic COI includes being an advisory member of the “haut conseil de santé publique”; a governmental advisory board on COVID-19 management and PI of the COVIDICUS study (PHRC 2020 NCT04344730) funded by the French Ministry of Health. EA has received fees for lectures from Gilead, Pfizer, Baxter, and Alexion. His research group has been supported by Ablynx, Fisher and Payckle, Jazz Pharma, and MSD. The other authors did not declare conflicts of interests.
Free to read: This content has been made available to all.